Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Stericycle Inc    SRCL

Delayed Quote. Delayed  - 09/23 10:00:00 pm
79.54 USD   +0.35%
09/24 STERICYCLE : Announces Its First Investor Day to Be Held on November..
09/23 Stericycle Announces Its First Investor Day to Be Held on Novembe..
09/23 STERICYCLE : Bard Associates Inc Lowers stake in Stericycle Inc (SRC..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Sales2 1432 5562 9863 5713 6993 841
Operating income (EBITDA)6457207899259661 029
Operating profit (EBIT)556615662716760837
Pre-Tax Profit (EBT)478-----
Net income311326255288369437
P/E ratio32,634,640,724,218,917,8
EPS ( $ )3,563,792,963,284,224,48
Dividend per Share ( $ )---0,22--
Yield---0,28%--
Reference price ( $ )116.17131.08120.679.5479.5479.54
Announcement Date02/05/2014
09:02pm
02/05/2015
09:02pm
02/04/2016
09:02pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Debt1 3691 6373 1581 1462 5322 095
Finance------
Operating income (EBITDA)6457207899259661 029
Leverage
(Debt/EBITDA)
2,12x2,27x4,00x1,24x2,62x2,04x
Capital Expenditure73,186,5115131135133
Book Value Per Share (BVPS)20,6 $22,4 $32,1 $33,1 $37,1 $42,6 $
Cash Flow per Share4,62 $5,20 $4,53 $5,33 $5,84 $6,37 $
Announcement Date02/05/2014
09:02pm
02/05/2015
09:02pm
02/04/2016
09:02pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 6 764 M$ -
Entreprise Value (EV) 7 910 M$ 9 296 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 24,2x 18,9x
Capitalization / Revenue 1,89x 1,83x
EV / Revenue 2,22x 2,51x
EV / EBITDA 8,55x 9,62x
Yield (DPS / Price) 0,28% -
Price to book (Price / BVPS) 2,41x 2,15x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 20,1% 20,5%
operating Leverage (Delta EBIT / Delta Sales) 0,42x 1,70x
Net Margin (Net Profit / Revenue) 8,07% 9,97%
ROA (Net Profit / Asset) 25,1% 7,44%
ROE (Net Profit / Equities) 12,7% 11,3%
Rate of Dividend 6,70% -
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   3,67% 3,64%
Cash Flow / Sales 12,7% 13,4%
Capital Intensity (Assets / Sales) 0,32x 1,34x
Financial Leverage (Net Debt / EBITDA) 1,24x 2,62x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend